Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02276495 · ClinicalTrials.gov registry record · NA

Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?

A NA study of Pain Management, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT02276495 is a NA study of Pain Management that has completed, run by University of California, Irvine. The registered enrollment target is 55 participants, below the 153-participant average among 31 other Pain Management trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02276495, a NA study of Pain Management, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the effect of a single injection adductor canal block (ACB) on pain scores within 24 hours post total knee arthroplasty (TKA).

Conditions Studied

Interventions

  • OTHER ACB Control - 20 ml saline injection for ACB
  • DRUG ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block
  • DRUG Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline

Study Locations (1)

California

  • University of California, Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2015-01-01
Est. Completion 2024-09-30
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT02276495

The ClinicalTrials.gov registry entry for NCT02276495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 31 other Pain Management trials with a reported enrollment target (64% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 3 interventions - of which ACB Control - 20 ml saline injection for ACB is the first listed.

NCT02276495 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02276495 about?

NCT02276495 is a clinical study titled "Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?". The purpose of the study is to determine the effect of a single injection adductor canal block (ACB) on pain scores within 24 hours post total knee arthroplasty (TKA).

What is the current status of trial NCT02276495?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-01-01. Estimated completion is 2024-09-30.

What conditions does trial NCT02276495 study?

This clinical trial studies the following conditions: Pain Management.

What interventions are being tested in trial NCT02276495?

The interventions under investigation include: ACB Control - 20 ml saline injection for ACB (OTHER), ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block (DRUG), Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline (DRUG).

Who is sponsoring clinical trial NCT02276495?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02276495 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.